Simplexa C. Auris Direct Assay Launched by Diasorin
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Tag: DiaSorin
All
Latest
All
Latest
DiaSorin Simplexa COVID & Flu A/B Assay Gets FDA Clearance
DiaSorin received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Simplexa COVID & Flu A/B Direct assay.
All
Latest
DiaSorin to Acquire Luminex for $1.8B
Through the acquisition, DiaSorin will gain access to Luminex’s molecular diagnostics multiplexing technology and a portfolio that will strengthen its existing offering while expanding its presence in the United States.
DiaSorin Molecular Receives BARDA Funding to Develop a Rapid COVID-19 Test
The product is expected to be CE marked and submitted to the FDA by the end of March 2020 to consider for emergency use authorization.
Read More
FDA Clears Simplexa VZV Swab Direct Molecular Assay
The moderate-complexity assay is designed to detect varicella-zoster virus DNA from cutaneous and mucocutaneous swab specimens.
Read More
FDA Approves QuantiFeron-TB Gold Plus Test for Liaison Platforms
The test enables highly automated screening for latent tuberculosis.
Read More
DiaSorin Molecular Introduces Primer Pair for Candida auris
DiaSorin Molecular has released a new primer pair that targets the yeast Candida auris, for use in creating laboratory-developed molecular tests
Read MoreHerpes Simplex and Varicella-Zoster Assay Receives CE Mark
Inclusion of VZV along with HSV-1 and HSV-2 testing may enable clinicians to provide improved therapeutic decisions and advice.
Read More
August/September Product News
This month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.
Read More
FDA Grants Extended Claims for DiaSorin HSV 1 & 2 Direct Assay
With clearance for additional sample types, the DiaSorin Molecular Simplexa HSV 1 & 2 assay now claims the most comprehensive sample type coverage for HSV testing on the market.
Read MoreDiaSorin Molecular Introduces Primers for A. phagocytophilum, Babesia, and Ehrlichia
The offerings join DiaSorin Molecular’s menu of more than 60 molecular reagents for bacterial, fungal, and viral targets.
Read More
January/February 2018 Product Spotlight: Laboratory Reagents and Consumables
This month’s issue features laboratory reagents and consumables from such companies as Audit Microcontrols, Bio-rad Laboratories, and Diasorin Molecular.
Read More
DiaSorin to Acquire Focus Diagnostics Unit for $300 Million
By purchasing Quest Diagnostics’ immunology and molecular diagnostic products business, DiaSorin looks to boost its presence in the growing market for infectious disease testing.
Read MoreDiaSorin and Beckman Coulter Partner to Reach Chinese Market
DiaSorin and Beckman Coulter have signed a partnership agreement for distribution of automated hepatitis and HIV tests and instruments in China.
Read More